We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in CUBIST PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 302 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 307 → 0 (-307)

100% less funds holding in top 10

Funds holding in top 10: 35 → 0 (-35)

100% less capital invested

Capital invested by funds: $8B → $0 (-$8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 302

Holders
–
Holders Change
-307
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-35
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
302
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$625M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$474M
3
BFA
BlackRock Fund Advisors
California
-$309M
4
State Street
State Street
Massachusetts
-$290M
5
HI
HBK Investments
Texas
-$287M
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
251
A.R.T. Advisors
New York
– -$287K -2,858 Closed
Commonwealth Equity Services
252
Commonwealth Equity Services
Massachusetts
– -$285K -2,833 Closed
CIM
253
Calvert Investment Management
Maryland
– -$284K -2,818 Closed
QI
254
Quotient Investors
New York
– -$278K -2,759 Closed
OA
255
Oak Associates
Ohio
– -$272K -2,700 Closed
BTS
256
BB&T Securities
Virginia
– -$2.59M -2,574 Closed
NFC
257
Northeast Financial Consultants
Connecticut
– -$257K -2,555 Closed
PWLP
258
Prio Wealth Limited Partnership
Massachusetts
– -$255K -2,534 Closed
NCCM
259
Nine Chapters Capital Management
New Jersey
– -$242K -2,400 Closed
TC
260
Taylor Cottrill
New Hampshire
– -$240K -2,388 Closed
Teacher Retirement System of Texas
261
Teacher Retirement System of Texas
Texas
– -$229K -2,278 Closed
LPL Financial
262
LPL Financial
California
– -$217K -2,155 Closed
Fisher Asset Management
263
Fisher Asset Management
Washington
– -$216K -2,150 Closed
CCM
264
Coldstream Capital Management
Washington
– -$214K -2,125 Closed
CIBC Asset Management
265
CIBC Asset Management
Ontario, Canada
– -$212K -2,107 Closed
Cambridge Investment Research Advisors
266
Cambridge Investment Research Advisors
Iowa
– -$205K -2,032 Closed
B
267
Barings
North Carolina
– -$201K -2,000 Closed
DSN
268
D. Scott Neal
Kentucky
– -$201K -2,000 Closed
MCM
269
Manchester Capital Management
Vermont
– -$200K -1,987 Closed
OA
270
OFI Advisors
Pennsylvania
– -$188K -1,863 Closed
VFA
271
Virtus Fund Advisers
Connecticut
– -$171K -1,696 Closed
Creative Planning
272
Creative Planning
Kansas
– -$170K -1,692 Closed
Bank of Montreal
273
Bank of Montreal
Ontario, Canada
– -$149K -1,479 Closed
US Bancorp
274
US Bancorp
Minnesota
– -$145K -1,445 Closed
RFC
275
Russell Frank Company
Washington
– -$120K -1,185 Closed
9 10
11
12 13

CBST Hedge Fund Activity: Q1 2015 in Review

0 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2015, worth a combined $0 — down 100% from $8B a quarter earlier.

Sellers outnumbered buyers: 302 funds closed out of CBST and 0 opened new positions — a net loss of 302 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $625M sold.

  • 0 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2015, down from 307 in Q4 2014.
  • Funds reported $0 of CUBIST PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2015 and 302 closed out, a net change of -302 holders.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $625M sold.

Based on aggregated 13F filings for Q1 2015.